Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-11-03
1996-09-03
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544 581, 544168, 544130, 544131, 544133, 540524, 540531, 514604, 546175, 546194, 546247, 546209, 546265, 5462834, 5462821, 546333, 546337, 5462804, 5462844, 5462817, 5462751, 548205, 5483351, 5483381, 549 13, 549 65, 549426, 564 84, 564 90, 564 92, 564 94, 5142378, 514311, 514331, 514332, 514341, 514365, 514396, 514406, 514432, 514445, 514451, 514602, C07D21342, A61K 3144
Patent
active
055524192
ABSTRACT:
The invention relates to the compounds of formula I ##STR1## pharmaceutically acceptable prodrug derivatives and pharmaceutically acceptable salts thereof; methods for preparation thereof; pharmaceutical compositions comprising said compounds; and a method of inhibiting matrix-degrading metalloproteinase and of treating matrix-degrading metalloproteinase dependent conditions in mammals using such compounds.
REFERENCES:
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4885027 (1989-12-01), Pomidor
patent: 4996358 (1991-02-01), Handa et al.
patent: 5114953 (1992-05-01), Galardy et al.
patent: 5137914 (1992-08-01), Ohtani et al.
patent: 5240958 (1993-08-01), Campion et al.
Tibtech, Jun. 1992, vol. 10, pp. 200-207.
Trends Biotechnol., vol. 10, No. 6, 1992, pp. 200-207.
Nature, vol. 370, Jul. 1994, pp. 218-220.
Nature, vol. 370, Aug. 1994, pp. 558-561.
Nature, vol. 370, Aug. 1994, pp. 555-557.
BioEssays, vol. 14, No. 7-Jul. 1992, pp. 455-463.
Annual Reports in Medicinal Chemistry, 25, pp. 177-184, 1989.
J. Med. Chem., 1989, 32, pp. 145-151.
Synthesis, 1985, pp. 929-931.
Chemical Abstr. 93:81521r, 1980.
Chemical Abstr. 59:3824a (1963).
Microchemical Journal, 40 pp. 226-232 (1989).
Chemical Abstr. 70:88228j, 1959.
Chemical Abstr. 59:3824b, Aug. 5, 1963.
MacPherson Lawrence J.
Parker David T.
Ciba-Geigy Corporation
Davis Zinna N.
Gruenfeld Norbert
Ivy C. Warren
LandOfFree
Arylsulfonamido-substituted hydroxamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamido-substituted hydroxamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamido-substituted hydroxamic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1950220